Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. | J Hematol Oncol | 2022 | 35765040 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer. | Front Cell Dev Biol | 2022 | 35757000 | PubTator, text mining | PubMed |
| Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4. | Int J Mol Sci | 2022 | 35742955 | PubTator, text mining | PubMed |
| PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma. | Cancer Res | 2022 | 35731926 | PubTator, text mining | PubMed |
| Long Noncoding RNA LINC00467: Role in Various Human Cancers. | Front Genet | 2022 | 35719391 | PubTator, text mining | PubMed |
| Application of Induced Pluripotent Stem Cell-Derived Models for Investigating microRNA Regulation in Developmental Processes. | Front Genet | 2022 | 35719367 | PubTator, text mining | PubMed |
| lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer. | Breast J | 2022 | 35711895 | PubTator, text mining | PubMed |
| The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology. | Reprod Biol Endocrinol | 2022 | 35706003 | PubTator, text mining | PubMed |
| Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. | J Nanobiotechnology | 2022 | 35701788 | PubTator, text mining | PubMed |
| Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction. | Nat Cell Biol | 2022 | 35697783 | PubTator, text mining | PubMed |
| Genome-wide causal mediation analysis identifies genetic loci associated with uterine fibroids mediated by age at menarche. | Hum Reprod | 2022 | 35689443 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Adipose-derived exosomes block muscular stem cell proliferation in aged mouse by delivering miRNA Let-7d-3p that targets transcription factor HMGA2. | J Biol Chem | 2022 | 35679898 | PubTator, text mining | PubMed |
| Cell fate roadmap of human primed-to-naive transition reveals preimplantation cell lineage signatures. | Nat Commun | 2022 | 35672317 | PubTator, text mining | PubMed |
| The Biological and Molecular Function of LINC00665 in Human Cancers. | Front Oncol | 2022 | 35664776 | PubTator, text mining | PubMed |
| The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. | Theranostics | 2022 | 35664076 | PubTator, text mining | PubMed |
| miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. | Mol Ther Oncolytics | 2022 | 35663229 | PubTator, text mining | PubMed |
| Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology. | Front Pharmacol | 2022 | 35662709 | PubTator, text mining | PubMed |
| CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4. | Dis Markers | 2022 | 35655916 | PubTator, text mining | PubMed |
| Comprehensive characterization of posttranscriptional impairment-related 3'-UTR mutations in 2413 whole genomes of cancer patients. | NPJ Genom Med | 2022 | 35654793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=26